Biosimilars Market Emerging Trend, Top Companies, Industry Demand and Regional Analysis by 2027

The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a CAGR of 49% during the forecast period 2021 to 2027.

Biosimilars are biological medical products that are very similar to other biological medicines that have already been approved. Biosimilars are approved under the same pharmaceutical quality, safety and efficacy standards that apply to all biological drugs. The global biosimilar market is driven by factors such as cost effectiveness and increasing demand for biosimilars due to the spread of chronic diseases. In addition, the pressure to reduce healthcare expenditures, along with expiration of patents for various blockbuster drugs and increased approval of biosimilar drugs by the FDA, is expected to accelerate market growth.

(Get 15% Discount on Buying this Report)

A full report of Global Biosimilars Market is available at: https://www.orionmarketreports.com/biosimilars-market/53530/

Market Segments

By Types

  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Others

By Applications

  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies
  • Others

Key Players

The prominent players operating in the biosimilars market include Pfizer (US), Sandoz (Germany), Biocon (India), Biogen (US), Fresenius Kabi AG (Germany),  Boehringer Ingelheim (Germany), Merck KgaA (Germany), Mylan (US), Eli Lilly (US), Teva Pharmaceutical (Israel), Dr. Reddy’s Laboratories (India), Amgen (US), Celltrion (South Korea), Samsung Biologics (South Korea), Amega Biotech (Argentina), mAbxience (Switzerland), Probiomed (Mexico), Apotex (Canada), Chong Kun Dang (South Korea), JCR Pharmaceuticals (Japan), Gan & Lee Pharmaceuticals (China), Gedeon Richter (Hungary), Biocad (Russia), Coherus Bioscience (US), and Stada Arzneimittel AG (Germany).

Scope of the Report

The research study analyzes the global Biosimilars industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Biosimilars Market Report

1. What was the Biosimilars Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Biosimilars Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Biosimilars Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

  • Proliferation and maturation of trade in the global Biosimilars market.
  • The market share of the global Biosimilars market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
  • Current and future market trends that are influencing the growth opportunities and growth rate of the global Biosimilars market.
  • Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Biosimilars market.

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)